RIACOAT T-4
510(k) K833745
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK833745 | Date4 Jan 1984 | StatusActive |
Recalls
No FDA recalls found in the data synced 5 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- CDX
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1700
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The RIACOAT T-4 is a Radioimmunoassay Kit for Total Thyroxine (T4), classified under Clinical Chemistry. It is designed to measure total thyroxine levels in plasma or serum samples using a coated-tube radioimmunoassay method. The assay relies on competitive binding between labeled and unlabeled thyroxine in the sample, enabling quantitative determination of T4 concentrations.
This device is supplied as a single-use diagnostic kit and requires incubation of undiluted samples, standards, and controls with tracer for 2 hours in thyroxine antibody-coated tubes. It is intended for in vitro diagnostic use in clinical chemistry laboratories, adhering to FDA clearance under 510(k) K833745 with a product code of CDX. No MRI safety or sterility specifications are noted in the available data.
Other devices from Immuno Assay Corp.
Questions
AI-generated answers, 1 Oct 2026
What is the RIACOAT T-4 used for?
The RIACOAT T-4 is a radioimmunoassay kit designed specifically for measuring total thyroxine (T4) levels in plasma or serum samples. It employs a coated-tube method where labeled and unlabeled thyroxine compete for binding sites on thyroxine antibody-coated tubes. This competitive binding allows for precise quantitative measurement of T4 concentrations, which is critical for diagnosing and monitoring thyroid-related conditions.
How is the RIACOAT T-4 kit supplied and used?
The RIACOAT T-4 is supplied as a single-use diagnostic kit. To perform the assay, undiluted samples, standards, and controls are incubated with tracer in the thyroxine antibody-coated tubes for 2 hours. This incubation period enables the competitive binding reaction to occur, allowing for the determination of T4 levels. The kit is intended exclusively for in vitro diagnostic use in clinical chemistry laboratories.
Is the RIACOAT T-4 kit sterile?
The provided data does not specify any sterility requirements or claims for the RIACOAT T-4 kit. Users should follow standard laboratory protocols for handling and preparing samples to ensure safety and accuracy, particularly since it is intended for in vitro diagnostic use.
Can the RIACOAT T-4 kit be reused?
The RIACOAT T-4 is explicitly designed as a single-use diagnostic kit. Reusing components could compromise the accuracy of results and potentially introduce contamination or cross-reactivity, which is why it is not recommended. Each kit is intended for one assay cycle only.
What regulatory pathway does the RIACOAT T-4 follow?
The RIACOAT T-4 received FDA clearance under the 510(k) pathway, specifically with clearance number K833745. It is classified under Clinical Chemistry and is substantially equivalent to a predicate device, as determined by the FDA. The product code assigned is CDX, indicating its classification in diagnostic clinical chemistry.